Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly -- Ignore unavailable to you. Want to Upgrade?

To: Sonki who wrote (140)	4/8/1998 5:56:00 PM
From: Anthony Wong	Read Replies (2) \| Respond to of 641

Sonki, you've made a good buy. If you managed to buy LLY under $60, and LLY returns to it's old high of $72 within this year, you'd have made a 20% profit. Since it is a laggard in the drug group, any good news may lift the price up. According to an earlier newswire, LLY is expected to present data in mid-May at an American Society of Clinical Oncology meeting on Evista and breast cancer. This just may give that extra push and you may see another 10% upside.